Treatment of hyperprolactinemia with cabergoline in a patient with peripartum cardiomyopathy on BIVAD may lead to rapid myocardial recovery.
Answers are grounded in this paper and cite their sources.
May indicate cabergoline benefit in peripartum cardiomyopathy on BIVAD; hypothesis-generating and should not yet change practice.
Peripartum cardiomyopathy (PPCMP) requiring mechanical circulatory support is rare; however, it is a life-threatening disease with recovery rates poorer than expected. Herein, we describe a case of successful recovery of a patient with PPCMP. Implantation of a biventricular ventricular assist device was performed; additionally, the patient's hyperprolactinemia was treated with cabergoline, resulting in a fast complete restoration of ventricular function.
No takes yet. Share an insight, caveat, or question.
Wiedemann et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: